Robert Southard, MD
Surgical Critical Care · Houston, TXNPI 1831340769
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $215,333 of the $215,368 with a category attached, or 100.0%. Zimmer Biomet accounts for 100.0% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2022 at $77,302 and has fallen 100.0% since, to $20 in 2024. Among surgical critical care clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 14 payments — averaging $15,383 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$215K
- Integra Lifesciences Corporation$20
- Baxter Healthcare$16
What the payments were for
- Royalty or licence$215,333100%
- Food & beverage$360%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 12 | $215,333 |
| Integra Lifesciences Corporation | 1 | $20 |
| Baxter Healthcare | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RibFix Blu$138,031
- RIBFIX BLU ADVANTAGE$77,302
How this compares
$215,368 in reported general payments places this provider in the 95th percentile of 104 surgical critical care providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tramadol Hcl | 20 | $56 |
Paid to pharmacies, not to this prescriber.
Other surgical critical care in Houston
- Samir AwadHouston$1.6M
- Rondel AlbaradoHouston$197K
- Daniel BonvilleHouston$28K
- Martin ZielinskiHouston$14K
- Subhasis ChatterjeeHouston$13K
- Melissa StewartHouston$12K
- Alexi BloomHouston$12K
- Celia LedetHouston$9K
- Todd HuzarHouston$9K
- Natasha BeckerHouston$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.